AOH1996, an Inhibitor of PCNA, Sensitises Breast Cancer Cells to Cytotoxic Chemotherapy
Introduction Breast cancer is the most prevalent cancer in women, constituting approximately 15% of all new cancer cases.1 Despite the ever-expanding range of molecularly targeted therapies that are available for breast cancer therapy, traditional …